C5 Ketone Compositions for Metabolic and Cognitive Support
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies fail to effectively address cognitive decline, traumatic brain injury, and metabolic disorders by inadequately increasing blood ketone levels and promoting ketosis, which are essential for improving mental and physical performance and weight management.
Innovation Solution
Administration of therapeutically effective amounts of C5 ketone bodies, such as beta-ketopentanoate and beta-hydroxypentanoate, alone or in combination with other compounds, to increase blood ketone levels, induce and maintain ketosis, and improve cognitive function, physical performance, and weight management.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If C5 ketone bodies are administered to increase blood ketone levels and promote ketosis, then cognitive function and physical performance are improved, but the complexity of the therapeutic regimen increases
Solution Approach 1:
The patent combines C5 ketone bodies with C4 ketone bodies (beta-hydroxybutyrate) and other compounds (amino acids, vitamins, minerals) into a single integrated composition. This merging approach delivers multiple therapeutic benefits simultaneously - increasing blood ketone levels, promoting ketosis, and supporting cognitive function - thereby improving reliability without requiring multiple separate interventions that would increase regimen complexity
Solution Approach 2:
The composition is designed with multi-functionality, where C5 ketone bodies serve multiple purposes: they increase blood ketone levels, promote and maintain ketosis, support cognitive function, and aid physical performance. This universal approach allows a single therapeutic intervention to address multiple health objectives, resolving the contradiction between improving cognitive reliability and maintaining simple regimen complexity
2Quantity of substance
If C5 ketone bodies are administered to increase blood ketone levels, then ketosis is promoted, but the dosage and administration frequency must be precisely controlled
Solution Approach 1:
The patent employs parameter changes by providing specific dosage ranges (approximately 1 to approximately 50 g of C5 ketone body) and administration frequencies (once daily to multiple times daily). These defined parameters establish precise control guidelines for achieving therapeutic blood ketone levels while promoting ketosis, thereby resolving the contradiction between increasing substance quantity and maintaining manufacturing precision
3Use of energy by moving object
If C5 ketone bodies are administered to improve physical performance, then energy levels increase, but the risk of adverse effects may increase
Solution Approach 1:
The patent introduces C4 ketone bodies (beta-hydroxybutyrate) and other compounds as intermediaries that work synergistically with C5 ketone bodies. These intermediary substances help modulate the metabolic response, ensuring that energy levels increase through controlled ketosis while minimizing the risk of adverse effects. The intermediary compounds act as buffers and facilitators, resolving the contradiction between improving energy utilization and reducing harmful factors
Data Source
AI summary
The present disclosure pertains to compositions and methods for the treatment and/or prevention of one or more of obesity, diabetes, metabolic syndrome, Alzheimer's disease, Chronic Fatigue Syndrome (CFS), aging, fibromyalgia, dyslipidemia, hypercholesterolemia, dyslipidemia, Parkinson's disease, migraines, Traumatic Brain Injury (TBI), Attention Deficit Disorder (ADD)/Attention Deficit Hyperactivity Disorder (ADHD), Cancer, Cardiovascular Disease (CVD)/Coronary Artery Disease (CAD), Chronic Pain, neuralgia, depression, amyotrophic lateral sclerosis (ALS), and epilepsy, Insufficient Cellular Energy (ICE) and mitochondrial dysfunction. The present disclosure also pertains to methods for increasing mental and/or physical performance levels and/or decreasing exertion during exercise in a subject by the administration of C5 ketones.